Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.
about
Function, regulation and pathological roles of the Gab/DOS docking proteinsFunctional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signalingPhosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking proteinActivation of a novel estrogen receptor, GPER, is cardioprotective in male and female ratsInhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerGenomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia.Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells.Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer.Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer.Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells.Modelling reveals novel roles of two parallel signalling pathways and homeostatic feedbacks in yeast.Survival of pancreatic cancer cells lacking KRAS function.PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras
P2860
Q21245511-D8DA04AE-765D-4064-9092-28DFEEC2C890Q24304242-91DD2104-CAAD-4FE7-80BF-0040210F8BB9Q24322676-92410FB9-D179-40A5-9E15-1304AAEF71F2Q29347039-32B1AEC2-BEC8-4CC2-8E6B-0706E35F4B89Q29618030-1A90C787-3EAE-4CF1-BE0D-9B25862D0B9DQ33399464-BE42BCBB-A823-44AA-B541-0E1C958766EBQ34687047-30300262-969C-4E5C-9101-53F015DD4638Q34786551-5B3F46EB-9BD7-44B8-A8A5-AA86B7B33322Q34824747-69B303A4-CA07-4CD2-A92B-FAAAADFAD0CCQ35839063-1A5379F6-2611-421F-9BFA-5E7281C4B5D8Q36557467-CC7330E6-3CB1-4E80-9F4B-E9DCE0B52FF1Q37738238-29F85823-953A-4411-93AC-A80C4F52BE89Q38132066-99967587-C885-479A-A2A8-56ED6C985F5CQ38817086-307BBEF1-6566-490E-8A86-9D60DA1AA360Q42431432-2CF886D4-F842-4351-A9C8-6583C44CD7DAQ42645888-C36F732C-2F6D-4253-8430-A1DF271B3430Q42760471-C85A1BCD-4424-4C7D-BA2D-437BF43683E4
P2860
Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Signal strength dictates phosp ...... th factor receptor inhibition.
@en
type
label
Signal strength dictates phosp ...... th factor receptor inhibition.
@en
prefLabel
Signal strength dictates phosp ...... th factor receptor inhibition.
@en
P2093
P2860
P50
P356
P1476
Signal strength dictates phosp ...... th factor receptor inhibition.
@en
P2093
Bertrand Perret
Carla Sampaio
Jean-Pierre Salles
Marie Dance
Nicole Malet
Patrick Raynal
P2860
P304
P356
10.1128/MCB.01318-07
P407
P577
2007-11-19T00:00:00Z